esketamine has been researched along with Subarachnoid Hemorrhage in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilera, AH; Dreier, JP; Hartings, JA; Herrera, MG; Kentar, M; Kola, V; Kunzmann, K; Lemale, CL; Major, S; Olivares-Rivera, A; Sakowitz, OW; Sánchez-Porras, R; Santos, E; Uhlmann, L; Unterberg, AW; Woitzik, J; Zerelles, R | 1 |
| Attou, R; De Bels, D; Gallerani, A; Honore, PM; Kugener, L; Mugisha, A; Redant, S | 1 |
2 other study(ies) available for esketamine and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Lasting s-ketamine block of spreading depolarizations in subarachnoid hemorrhage: a retrospective cohort study.
Topics: Adult; Aged; Cohort Studies; Female; Humans; Hypnotics and Sedatives; Ketamine; Length of Stay; Male; Midazolam; Middle Aged; N-Methylaspartate; Neuromuscular Depolarizing Agents; Odds Ratio; Retrospective Studies; Subarachnoid Hemorrhage | 2019 |
High doses of ketamine to improve neuronal edema in subarachnoid hemorrhage: we should consider other undesirable organ targets.
Topics: Edema; Humans; Ketamine; Retrospective Studies; Subarachnoid Hemorrhage | 2020 |